IP Verse

Samsung Bioepis Co., Ltd. competitive analysis

Latest oppositions filed by Samsung Bioepis Co., Ltd.

Explore patent oppositions filed by Samsung Bioepis Co., Ltd. against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP2894165
Methods And Compositions For Treating Complement-Associated DisordersALEXION PHARMACEUTICALSOct 4, 2023

Latest patents of Samsung Bioepis Co., Ltd. opposed by its competitors

Explore Samsung Bioepis Co., Ltd.'s recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3730126
May 14, 2025Liquid Composition Comprising Vegf Antagonist3
EP3036320
Apr 3, 2024Control Of Protein Glycosylation By Culture Medium Supplementation And Cell Culture Process Parameters1
EP3122869
Aug 10, 2022Methods For Overcoming Glutamine Deprivation During Mammalian Cell Culture1

Latest PTAB cases involving Samsung Bioepis Co., Ltd.

Discover the latest PTAB cases involving Samsung Bioepis Co., Ltd., highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Samsung Bioepis Co., Ltd. with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SAMSUNG BIOEPIS6518 -
ABG LAW11 - - -
ALEXION PHARMACEUTICALS39 - 8
KILBURN & STRODE19 - - -